Tables 1.

Key Federal Policy Recommendations to Combat AMR

Issues	Recommendations
Surveillance/data collection	Increase CDC funding to facilitate the necessary surveillance, including making specific resistant pathogens reportable in all hospitals nationwide.
Stewardship	Deepen funding and coordination of efforts to strengthen stewardship, including expanding the workforce and improving measurement of antibiotic use and appropriateness.
Innovation	Enact the PASTEUR Act to pay for novel antimicrobials based on value, not volume, and reinvigorate the antibiotic pipeline.
Diagnostics	Increase funding to support research and development of diagnostics that can rapidly provide accurate, actionable results on antimicrobial susceptibility. Support outcomes studies to inform impact on antibiotic use and stewardship, educational materials, and reimbursement of tests.
Research	Expand AMR research funding, including to support a clinical trials network to conduct large-scale and pragmatic studies of antibiotics for antibiotic-resistant infections.
Infection prevention	Strengthen community-based prevention (including immunization uptake) and facility-based prevention, such as containment measures recommended by CDC.
Workforce	Provide appropriate compensation, loan repayment and training opportunities for the infectious diseases workforce, spanning clinical, research, and public health settings.
Global coordination	Expand US funding to support AMR surveillance, stewardship, and prevention in low resource countries and strengthen coordination with WHO.

Abbreviations: AMR, antimicrobial resistance; CDC, Centers for Disease Control and Prevention; PASTEUR, Pioneering Antibiotic Subscriptions to End Upsurging Resistance; WHO, World Health Organization.